The supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to hit the market and disrupt the medical sector
binds GLP-1 receptors on pancreatic -cells (stimulating glucose-dependent insulin secretion), -cells (suppressing glucagon), gastrointestinal tract (slowing gastric emptying), and hypothalamic neurons (suppressing appetite and food intake via arcuate nucleus signaling)
Chen M, Li H, Li Y, Luo Y, He Y, Shui X, Lei W
Liver fat reduction was dramatic, with up to 82% reduction in hepatic fat content among participants with fatty liver at baseline
To maintain your weight loss after stopping GLP-1 medications, sticking to healthy lifestyle habits is key